Discover
ACET
Adicet Bio, Inc.
9.18
1 x 9.15
1 x 9.19
bid
ask
+
0.17
1.89%
1 @ 07:48 PM
9.00 -0.18 (1.97%)
| Ytd | 9.03% | |
| 1y | -29.17% |
8.77
day range
9.38
6.11
52 week range
16.64
| Open | 8.96 | Prev Close | 9.01 | Low | 8.77 | High | 9.38 | Mkt Cap | 85.94M |
| Vol | 114.53K | Avg Vol | 102.56K | EPS | -10.42 | P/E | N/A | Forward P/E | -0.69 |
| Beta | 1.70 | Short Ratio | 7.04 | Inst. Own | 76.44% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 8.80 | 200-d Avg | 8.06 | 1yr Est | 6.40 |
| Income Statement | |||
| Operating Expenses | 22.30M | ||
| Research and Development Expense | 18.45M | ||
| Selling, General and Administrative Expense | 3.85M | ||
| Operating Income | -22.30M | ||
| Interest Expense | 22.00K | ||
| Income Tax Expense | 143.00K | ||
| Net Income | -21.36M | ||
| Net Income Common Stock | -21.36M | ||
| Net Income Common Stock (USD) | -21.36M | ||
| Consolidated Income | -21.36M | ||
| Earnings per Basic Share | -1.99 | ||
| Earnings per Basic Share (USD) | -1.99 | ||
| Earnings per Diluted Share | -1.99 | ||
| Earning Before Interest & Taxes (EBIT) | -21.19M | ||
| Earning Before Interest & Taxes (USD) | -21.19M | ||
| Weighted Average Shares | 10.75M | ||
| Weighted Average Shares Diluted | 10.75M | ||
| Balance Sheet | |||
| Cash and Equivalents | 36.00M | ||
| Cash and Equivalents (USD) | 36.00M | ||
| Investments | 85.06M | ||
| Investments Current | 85.06M | ||
| Current Assets | 120.76M | ||
| Property, Plant & Equipment Net | 24.45M | ||
| Total Assets | 148.17M | ||
| Debt Current | 2.83M | ||
| Total Debt | 12.85M | ||
| Current Liabilities | 18.00M | ||
| Debt Non-Current | 10.03M | ||
| Total Liabilities | 28.03M | ||
| Accumulated Retained Earnings (Deficit) | -656.30M | ||
| Accumulated Other Comprehensive Income | -105.00K | ||
| Shareholders Equity | 120.14M | ||
| Shareholders Equity (USD) | 120.14M | ||
| Assets Non-Current | 27.40M | ||
| Total Debt (USD) | 12.85M | ||
| Liabilities Non-Current | 10.03M | ||
| Trade and Non-Trade Payables | 3.59M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.95M | ||
| Net Cash Flow from Financing | 58.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.11M | ||
| Capital Expenditure | -202.00K | ||
| Issuance (Purchase) of Equity Shares | 83.00K | ||
| Net Cash Flow from Investing | 16.65M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 16.85M | ||
| Net Cash Flow from Operations | -19.82M | ||
| Share Based Compensation | 1.44M | ||